Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials
Abstract Objective To compare the outcomes associated with the use of lasmiditan, rimegepant, ubrogepant, and zavegepant for the acute management of migraine headaches. Methods We searched four electronic databases from database inception to August 31, 2023, to identify randomized controlled trials...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2024-02-01
|
| سلاسل: | The Journal of Headache and Pain |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s10194-024-01723-4 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|